Indication

Xerostomia secondary to radiation therapy

Xerostomia secondary to radiation therapy is a treatment-induced oral complication characterized by the subjective sensation of dry mouth accompanied by salivary gland hypofunction. Read more about Xerostomia secondary to radiation therapy

17 drugs 16 manufacturers

Advertisement

Drugs that treat it

Common Xerostomia secondary to radiation therapy therapies.

Showing 10–17 of 17 drugs

Filter & compare in the drug finder →Opens the drug finder with Xerostomia secondary to radiation therapy preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Xerostomia secondary to radiation therapy.

Xerostomia secondary to radiation therapy is a treatment-induced oral complication characterized by the subjective sensation of dry mouth accompanied by salivary gland hypofunction.

It primarily affects oncology patients receiving ionizing radiation directed to the head and neck region, resulting in collateral damage to major and minor salivary glands within the treatment field.

Pathophysiologically, ionizing radiation induces acute apoptosis and chronic necrosis of secretory acinar cells, progressive interstitial fibrosis, microvascular injury, and loss of functional glandular parenchyma.

Clinically, this leads to a profound reduction in salivary flow rate and altered saliva composition, frequently causing oral soreness, difficulty with mastication and deglutition, dysgeusia, accelerated dental caries, and heightened susceptibility to oral candidiasis.

Personalize your experience

Follow Xerostomia secondary to radiation therapy and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it